How Ph.D. was paid
$3.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Sean Bohen, M.D., Ph.D.President and Chief Executive Officer | $699,920 | — | $2,002,000 | $461,900 | $15,170 | $3,178,990 |
| Shane KovacsChief Operating and Financial Officer | $562,640 | — | $985,600 | $324,925 | $15,170 | $1,888,335 |
| Shawnte Mitchell, J.D.Chief Legal Officer and Corporate Secretary | $391,875 | $50,000 | $1,386,000 | $207,900 | $14,975 | $2,050,750 |
What changed and why
- $8.1MCEO total compensation decreased from $8,130,556 in 2024 to $3,178,990 in 2025 primarily due to lower option award values.
- 110%Corporate achievement for 2025 was determined to be 110% based on clinical development milestones.
- $700KDr. Bohen received a base salary of $699,920 for 2025, reflecting an increase from the prior year.
- $50,000Shawnte Mitchell joined the company as Chief Legal Officer and received a sign-on bonus of $50,000.
- 25%Stock options granted in 2025 generally vest 25% after one year with monthly vesting thereafter.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.